HEADER METAL BINDING PROTEIN 15-JUL-09 3IB1 TITLE STRUCTURAL BASIS OF THE PREVENTION OF NSAID-INDUCED DAMAGE OF THE TITLE 2 GASTROINTESTINAL TRACT BY C-TERMINAL HALF (C-LOBE) OF BOVINE TITLE 3 COLOSTRUM PROTEIN LACTOFERRIN: BINDING AND STRUCTURAL STUDIES OF C- TITLE 4 LOBE COMPLEX WITH INDOMETHACIN CAVEAT 3IB1 THR A 557 HAS WRONG CHIRALITY AT ATOM CB MAN C 3 HAS WRONG CAVEAT 2 3IB1 CHIRALITY AT ATOM C1 MAN C 5 HAS WRONG CHIRALITY AT ATOM C1 CAVEAT 3 3IB1 MAN C 6 HAS WRONG CHIRALITY AT ATOM C1 CHIRALITY ERROR AT CAVEAT 4 3IB1 CB CENTER OF THR A 557 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LACTOTRANSFERRIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 361-705; COMPND 5 SYNONYM: LACTOFERRIN, LACTOFERRICIN-B, LFCIN-B; COMPND 6 EC: 3.4.21.- SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913 KEYWDS C-LOBE, DRUGS, METAL BINDING PROTEIN, ANTIBIOTIC, ANTIMICROBIAL, KEYWDS 2 DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, ION TRANSPORT, IRON, IRON KEYWDS 3 TRANSPORT, METAL-BINDING, PHOSPHOPROTEIN, PROTEASE, SECRETED, SERINE KEYWDS 4 PROTEASE, TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR R.MIR,N.SINGH,M.SINHA,S.SHARMA,P.KAUR,A.SRINIVASAN,T.P.SINGH REVDAT 8 09-OCT-24 3IB1 1 REMARK REVDAT 7 01-NOV-23 3IB1 1 HETSYN REVDAT 6 29-JUL-20 3IB1 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 15-AUG-18 3IB1 1 COMPND SOURCE SEQADV REVDAT 4 01-AUG-18 3IB1 1 COMPND SOURCE JRNL REVDAT 3 13-JUL-11 3IB1 1 VERSN REVDAT 2 09-FEB-10 3IB1 1 JRNL REVDAT 1 11-AUG-09 3IB1 0 SPRSDE 11-AUG-09 3IB1 2ALT 3HWZ JRNL AUTH R.MIR,N.SINGH,G.VIKRAM,R.P.KUMAR,M.SINHA,A.BHUSHAN,P.KAUR, JRNL AUTH 2 A.SRINIVASAN,S.SHARMA,T.P.SINGH JRNL TITL THE STRUCTURAL BASIS FOR THE PREVENTION OF NONSTEROIDAL JRNL TITL 2 ANTIINFLAMMATORY DRUG-INDUCED GASTROINTESTINAL TRACT DAMAGE JRNL TITL 3 BY THE C-LOBE OF BOVINE COLOSTRUM LACTOFERRIN JRNL REF BIOPHYS.J. V. 97 3178 2009 JRNL REFN ISSN 0006-3495 JRNL PMID 20006955 JRNL DOI 10.1016/J.BPJ.2009.09.030 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.0 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 17853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 952 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1327 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE SET COUNT : 72 REMARK 3 BIN FREE R VALUE : 0.3620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2604 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 162 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.51000 REMARK 3 B22 (A**2) : -1.26000 REMARK 3 B33 (A**2) : -1.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.53000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.348 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.241 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.219 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.951 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2832 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3857 ; 2.231 ; 2.019 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 339 ; 5.708 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 466 ;20.429 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 448 ; 0.202 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2062 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1124 ; 0.258 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 283 ; 0.190 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 5 ; 0.291 ; 0.500 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.483 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.206 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1693 ; 1.046 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2700 ; 1.927 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1139 ; 2.626 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1157 ; 4.414 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IB1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054188. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 291 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17853 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 62.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1NKX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG MONOMETHYL ETHER-550, 0.1M REMARK 280 MES, 0.01M ZNSO4, PH6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.32700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 677 REMARK 465 SER A 678 REMARK 465 PRO A 679 REMARK 465 LEU A 680 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ZN ZN A 302 O HOH A 809 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 429 C - N - CD ANGL. DEV. = -14.9 DEGREES REMARK 500 PRO A 655 C - N - CD ANGL. DEV. = -12.8 DEGREES REMARK 500 PRO A 655 CA - N - CD ANGL. DEV. = -13.7 DEGREES REMARK 500 THR A 663 CA - CB - OG1 ANGL. DEV. = 22.4 DEGREES REMARK 500 THR A 663 CA - CB - CG2 ANGL. DEV. = -9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 431 -43.80 -144.14 REMARK 500 TRP A 467 -66.09 -139.96 REMARK 500 ALA A 482 39.76 -86.45 REMARK 500 GLN A 510 9.16 -68.67 REMARK 500 VAL A 543 -153.61 -130.36 REMARK 500 GLU A 583 30.38 -99.20 REMARK 500 ALA A 590 162.91 177.64 REMARK 500 PRO A 626 30.13 -99.13 REMARK 500 PHE A 632 42.40 -98.75 REMARK 500 THR A 636 28.59 47.47 REMARK 500 LEU A 640 -52.83 67.84 REMARK 500 ARG A 654 73.24 54.23 REMARK 500 ALA A 683 143.15 -170.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS A 633 -11.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 659 OE1 REMARK 620 2 GLU A 659 OE2 58.6 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 303 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 588 NE2 REMARK 620 2 HOH A 820 O 89.2 REMARK 620 3 HOH A 821 O 126.3 66.6 REMARK 620 4 HOH A 842 O 107.2 68.9 107.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE A 690 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 395 OD1 REMARK 620 2 TYR A 433 OH 98.6 REMARK 620 3 TYR A 526 OH 163.0 98.2 REMARK 620 4 HIS A 595 NE2 84.2 92.4 92.6 REMARK 620 5 CO3 A 691 O1 80.3 154.2 85.6 113.0 REMARK 620 6 CO3 A 691 O2 85.6 89.5 97.0 169.9 64.6 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ALT RELATED DB: PDB REMARK 900 SEQUESTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) BY REMARK 900 LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF REMARK 900 BOVINE LACTOFERRIN WITH INDOMETHACIN AT 2.2 A RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 NATURAL MUTATIONS HAVE OCCURRED AT 584 ASN AND 627 LYS. DBREF 3IB1 A 342 686 UNP P24627 TRFL_BOVIN 361 705 SEQADV 3IB1 LYS A 565 UNP P24627 ASN 584 SEE SEQUENCE DETAILS SEQADV 3IB1 GLU A 608 UNP P24627 LYS 627 SEE SEQUENCE DETAILS SEQRES 1 A 345 TYR THR ARG VAL VAL TRP CYS ALA VAL GLY PRO GLU GLU SEQRES 2 A 345 GLN LYS LYS CYS GLN GLN TRP SER GLN GLN SER GLY GLN SEQRES 3 A 345 ASN VAL THR CYS ALA THR ALA SER THR THR ASP ASP CYS SEQRES 4 A 345 ILE VAL LEU VAL LEU LYS GLY GLU ALA ASP ALA LEU ASN SEQRES 5 A 345 LEU ASP GLY GLY TYR ILE TYR THR ALA GLY LYS CYS GLY SEQRES 6 A 345 LEU VAL PRO VAL LEU ALA GLU ASN ARG LYS SER SER LYS SEQRES 7 A 345 HIS SER SER LEU ASP CYS VAL LEU ARG PRO THR GLU GLY SEQRES 8 A 345 TYR LEU ALA VAL ALA VAL VAL LYS LYS ALA ASN GLU GLY SEQRES 9 A 345 LEU THR TRP ASN SER LEU LYS ASP LYS LYS SER CYS HIS SEQRES 10 A 345 THR ALA VAL ASP ARG THR ALA GLY TRP ASN ILE PRO MET SEQRES 11 A 345 GLY LEU ILE VAL ASN GLN THR GLY SER CYS ALA PHE ASP SEQRES 12 A 345 GLU PHE PHE SER GLN SER CYS ALA PRO GLY ALA ASP PRO SEQRES 13 A 345 LYS SER ARG LEU CYS ALA LEU CYS ALA GLY ASP ASP GLN SEQRES 14 A 345 GLY LEU ASP LYS CYS VAL PRO ASN SER LYS GLU LYS TYR SEQRES 15 A 345 TYR GLY TYR THR GLY ALA PHE ARG CYS LEU ALA GLU ASP SEQRES 16 A 345 VAL GLY ASP VAL ALA PHE VAL LYS ASN ASP THR VAL TRP SEQRES 17 A 345 GLU ASN THR ASN GLY GLU SER THR ALA ASP TRP ALA LYS SEQRES 18 A 345 ASN LEU LYS ARG GLU ASP PHE ARG LEU LEU CYS LEU ASP SEQRES 19 A 345 GLY THR ARG LYS PRO VAL THR GLU ALA GLN SER CYS HIS SEQRES 20 A 345 LEU ALA VAL ALA PRO ASN HIS ALA VAL VAL SER ARG SER SEQRES 21 A 345 ASP ARG ALA ALA HIS VAL GLU GLN VAL LEU LEU HIS GLN SEQRES 22 A 345 GLN ALA LEU PHE GLY LYS ASN GLY LYS ASN CYS PRO ASP SEQRES 23 A 345 LYS PHE CYS LEU PHE LYS SER GLU THR LYS ASN LEU LEU SEQRES 24 A 345 PHE ASN ASP ASN THR GLU CYS LEU ALA LYS LEU GLY GLY SEQRES 25 A 345 ARG PRO THR TYR GLU GLU TYR LEU GLY THR GLU TYR VAL SEQRES 26 A 345 THR ALA ILE ALA ASN LEU LYS LYS CYS SER THR SER PRO SEQRES 27 A 345 LEU LEU GLU ALA CYS ALA PHE MODRES 3IB1 ASN A 368 ASN GLYCOSYLATION SITE MODRES 3IB1 ASN A 476 ASN GLYCOSYLATION SITE MODRES 3IB1 ASN A 545 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET MAN C 6 11 HET ZN A 302 1 HET ZN A 303 1 HET FE A 690 1 HET CO3 A 691 4 HET SO4 A 301 5 HET NAG A 1 14 HET IMN A 701 25 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM ZN ZINC ION HETNAM FE FE (III) ION HETNAM CO3 CARBONATE ION HETNAM SO4 SULFATE ION HETNAM IMN INDOMETHACIN HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 3 MAN 4(C6 H12 O6) FORMUL 4 ZN 2(ZN 2+) FORMUL 6 FE FE 3+ FORMUL 7 CO3 C O3 2- FORMUL 8 SO4 O4 S 2- FORMUL 10 IMN C19 H16 CL N O4 FORMUL 11 HOH *244(H2 O) HELIX 1 1 GLY A 351 SER A 365 1 15 HELIX 2 2 THR A 376 LYS A 386 1 11 HELIX 3 3 ASP A 395 CYS A 405 1 11 HELIX 4 4 THR A 447 LEU A 451 5 5 HELIX 5 5 TRP A 467 GLY A 479 1 13 HELIX 6 6 TYR A 524 GLU A 535 1 12 HELIX 7 7 ASN A 545 ASN A 551 1 7 HELIX 8 8 LYS A 565 GLU A 567 5 3 HELIX 9 9 PRO A 580 CYS A 587 5 8 HELIX 10 10 ARG A 603 GLY A 619 1 17 HELIX 11 11 THR A 656 GLY A 662 1 7 HELIX 12 12 GLY A 662 LYS A 674 1 13 SHEET 1 A 2 VAL A 345 VAL A 350 0 SHEET 2 A 2 VAL A 369 ALA A 374 1 O ALA A 372 N ALA A 349 SHEET 1 B 4 ALA A 391 LEU A 394 0 SHEET 2 B 4 ALA A 596 ARG A 600 -1 O ALA A 596 N LEU A 394 SHEET 3 B 4 LEU A 407 ASN A 414 -1 N VAL A 408 O SER A 599 SHEET 4 B 4 CYS A 647 ALA A 649 -1 O ALA A 649 N ALA A 412 SHEET 1 C 6 GLN A 489 CYS A 491 0 SHEET 2 C 6 LYS A 455 HIS A 458 1 N HIS A 458 O CYS A 491 SHEET 3 C 6 VAL A 540 LYS A 544 1 O VAL A 540 N CYS A 457 SHEET 4 C 6 TYR A 433 LYS A 440 -1 N VAL A 438 O ALA A 541 SHEET 5 C 6 PHE A 569 LEU A 572 -1 O ARG A 570 N VAL A 439 SHEET 6 C 6 ARG A 578 LYS A 579 -1 O LYS A 579 N LEU A 571 SHEET 1 D 5 GLN A 489 CYS A 491 0 SHEET 2 D 5 LYS A 455 HIS A 458 1 N HIS A 458 O CYS A 491 SHEET 3 D 5 VAL A 540 LYS A 544 1 O VAL A 540 N CYS A 457 SHEET 4 D 5 TYR A 433 LYS A 440 -1 N VAL A 438 O ALA A 541 SHEET 5 D 5 ALA A 590 ALA A 592 -1 O ALA A 592 N TYR A 433 SSBOND 1 CYS A 348 CYS A 380 1555 1555 2.04 SSBOND 2 CYS A 358 CYS A 371 1555 1555 2.05 SSBOND 3 CYS A 405 CYS A 684 1555 1555 1.81 SSBOND 4 CYS A 425 CYS A 647 1555 1555 1.77 SSBOND 5 CYS A 457 CYS A 532 1555 1555 1.99 SSBOND 6 CYS A 481 CYS A 675 1555 1555 2.01 SSBOND 7 CYS A 491 CYS A 505 1555 1555 1.68 SSBOND 8 CYS A 502 CYS A 515 1555 1555 2.26 SSBOND 9 CYS A 573 CYS A 587 1555 1555 2.11 SSBOND 10 CYS A 625 CYS A 630 1555 1555 2.04 LINK C1 NAG A 1 ND2 ASN A 368 1555 1555 1.40 LINK ND2 ASN A 476 C1 NAG B 1 1555 1555 1.51 LINK ND2 ASN A 545 C1 NAG C 1 1555 1555 1.42 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.46 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.51 LINK O4 MAN C 3 C1 MAN C 4 1555 1555 1.57 LINK O4 MAN C 4 C1 MAN C 5 1555 1555 1.47 LINK O4 MAN C 5 C1 MAN C 6 1555 1555 1.48 LINK ZN ZN A 302 OE1 GLU A 659 1555 1555 2.39 LINK ZN ZN A 302 OE2 GLU A 659 1555 1555 2.12 LINK ZN ZN A 303 NE2 HIS A 588 1555 1555 1.97 LINK ZN ZN A 303 O HOH A 820 1555 1555 2.38 LINK ZN ZN A 303 O HOH A 821 1555 1555 2.21 LINK ZN ZN A 303 O HOH A 842 1555 1555 1.84 LINK OD1 ASP A 395 FE FE A 690 1555 1555 1.81 LINK OH TYR A 433 FE FE A 690 1555 1555 2.05 LINK OH TYR A 526 FE FE A 690 1555 1555 1.91 LINK NE2 HIS A 595 FE FE A 690 1555 1555 2.16 LINK FE FE A 690 O1 CO3 A 691 1555 1555 2.03 LINK FE FE A 690 O2 CO3 A 691 1555 1555 2.35 CISPEP 1 CYS A 625 PRO A 626 0 8.60 CRYST1 63.839 50.654 66.119 90.00 107.56 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015664 0.000000 0.004957 0.00000 SCALE2 0.000000 0.019742 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015863 0.00000